Table 3 |
|||||
|
Clinical data of patients who received stings II. |
|||||
|
Total |
Bee |
Wasp |
Paperwasp |
P # |
|
|
|
|||||
|
Number of patients |
37 |
22 |
13 |
2 |
|
|
Number of patients with allergic reactions during immunotherapy |
16 (43.2%) |
12 (54.5%) |
4 (30.8%) |
0 |
NS |
|
Reactions/injections |
33 (3.4%) |
27 (4.7%) |
6 (1.5%) |
0 |
< 0.01 |
|
Reactions/patients |
|||||
|
I * |
15 (40.5%) |
11 (50.0%) |
4 (30.8%) |
0 |
NS |
|
II |
18 (48.6%) |
16 (72.7%) |
2 (15.4%) |
0 |
< 0.01 |
|
III–IV |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 |
|
|
|
|||||
|
# Statistical comparison between bee and wasp venom treated patients. * Classified according to Mueller[11]: Grade I – urticaria, pruritus, malaise; grade II – angioedema, chest tightness, nausea, vomiting, abdominal pain, dizziness; grade III – dispnoea, wheeze, stridor, dysphagia, hoarseness; grade IV – hypotension, collapse, loss of consciousness, incontinence, cyanosis. |
|||||
|
Mingomataj et al. BMC Dermatology 2002 2:11 doi:10.1186/1471-5945-2-11 |
|||||
